Use of Pathological Response Versus RECIST Assessment in Predicting Relapse-Free Survival Following Neoadjuvant Immunotherapy for Hepatocellular Carcinoma.
Journal of Clinical Oncology(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2025)